retatrutide triple agonist gip glp-1 glucagon phase 2 obesity for Obesity: Weight-Loss Data Triple G Agonists – Retatrutide.

In a study of two psoriasis patients with diabetes, liraglutide therapy for 6 weeks resulted in rapid clinical improvement, characterized by increased circulating i NKT cells and they also demonstrated in vitro that GLP-1 induced a dose-dependent reduction of cytokine secretion from i NKT cells [77]

Millions of peoplemany without diabetes or severe obesityare now on GLP-1s

What the Research Suggests About Weight Regain Clinical research supports the idea that ongoing management matters

Nooms recent pivot to include GLP-1 support exemplifies this trend

The long view, because perimenopause and GLP-1 progress often move less neatly than people expect